Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
6.26
+0.46 (7.93%)
At close: Jul 20, 2026, 4:00 PM EDT
6.29
+0.03 (0.48%)
Pre-market: Jul 21, 2026, 4:51 AM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $2.18 billion as of July 21, 2026. Its market cap has increased by 178.52% in one year.
Market Cap
2.18B
Enterprise Value
1.86B
1-Year Change
178.52%
Ranking
Category
Stock Price
$6.26
ChartMarket Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $2.18B, an increase of 1,149.29%. That is a compound annual growth rate of 53.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 2.18B | -29.04% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 2.07B |
| Aurinia Pharmaceuticals | 2.05B |
| Rapport Therapeutics | 2.04B |
| Syndax Pharmaceuticals | 2.02B |
| ADMA Biologics | 2.02B |
| Viridian Therapeutics | 1.99B |
| AbCellera Biologics | 1.97B |
| GH Research | 1.97B |